SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Mary Shelley — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMary Shelley
Date of birth1797-08-30
IdentifiersMRN HR-NI028-SYN-TD; SSN (made up) 000-28-6194
Document date1849-09-29
AuthorRosamund Achterberg-Ilesanmi, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-month review after resection: seizures, mood, and writing. [S]

History of Present Illness

Ms. Shelley returns about six months after resection of her meningioma. She has had no seizure since starting levetiracetam, about six and a half months ago, including during the stomach illness in August, when she vomited one dose. She drives again, keeps regular hours, and drinks little. Her mood is good; she finished her course with the counselor after eight sessions and says she can now speak of her old griefs without being undone by them. She writes every morning and has nearly finished her travel book. She has no headaches. [S]

ElementDetail
SeizuresNone since starting levetiracetam
MoodGood; counseling completed after eight sessions
WritingEvery morning; travel book nearly finished
GastroenteritisResolved in four days

Review of Systems

SystemResultFinding
NeurologicalNegativeNo seizures, aura, headaches, or weakness
GastrointestinalNegativeBowels normal since August
PsychiatricNegativeMood good; no irritability; no thoughts of suicide
ConstitutionalNegativeWeight stable; sleeping well

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Levetiracetam 500 mg oral tablet, one tablet by mouth twice a dayOne tablet twice a dayOral route1849-03-17activeS
Dexamethasone 4 mg oral tablet, one tablet twice a day for three days before surgery, then tapered and stopped over ten days after surgeryOne tablet twice a day, then taperingOral route1849-04-04 to 1849-04-17completedS
Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for headache or wound pain, no more than 3000 mg a dayTwo tablets up to every 8 hours as neededOral route1848-09-01activeS
Ondansetron 4 mg orally disintegrating tablet, one tablet on the tongue every 8 hours as needed for vomiting, for up to two daysOne tablet every 8 hours as needed for vomitingOral route1849-08-11 to 1849-08-13completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1849-09-29Body height160cmS
1849-09-29Body weight57.4kgS
1849-09-29Body mass index (BMI) [Ratio]22.4kg/m2S
1849-09-29Systolic blood pressure118mm[Hg]S
1849-09-29Diastolic blood pressure74mm[Hg]S
1849-09-29Heart rate68/minS
1849-09-29Respiratory rate14/minS
1849-09-29Body temperature36.5CelS
1849-09-29Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1849-09-29Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
1849-09-29Total score [MoCA]29{score}S
1849-09-29Creatinine [Mass/volume] in Serum or Plasma0.76mg/dL0.59-1.04 mg/dLNormalS
1849-09-29Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1844)/1.73 sq M95mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS

Physical Exam

Vital signs recorded on 1849-09-29; see the Vital Signs section. [S]

SystemFinding
GeneralWell
NeurologicalNormal: speech, strength, finger tapping, reflexes, and gait
Mental statusBright, articulate, and reflective; MoCA 29

Problems

ProblemClinical statusVerificationCodeProvenance
Headaches, worse in the morning, for about two years, with episodes over six months of tingling and weakness of the right hand and leg lasting a few minutes, one with twitching of the right fingers and one with difficulty finding words; mild right-hand weakness on examination; cause not yet established; urgent MRI and EEG bookedresolvedconfirmed R29.818S — Synthetic presenting concern at the index visit, superseded by the MRI and EEG diagnosis; her documented headaches with transient right-sided paralysis from 1839 are echoed.
Meningioma of the left frontoparietal convexity over the hand area of the motor cortex, 3.1 x 2.7 x 2.6 cm, with moderate vasogenic edema; resected (Simpson grade I); meningothelial meningioma, CNS WHO grade 1; synthetic modern counterpart of the supposed tumour of the left hemisphere on her death certificateactiveconfirmed D32.0S — Synthetic modern diagnosis. Her symptoms and the certificate's wording are documented (D); a brain tumour is a retrospective interpretation (R) disputed by the hemiplegic migraine and stroke hypothesis, and no tissue exists, so this meningioma is not presented as her historical diagnosis.
Focal epilepsy due to the left convexity meningioma: focal aware sensory and motor seizures of the right hand and arm, one with speech arrest; EEG with left central sharp waves; on levetiracetamactiveconfirmed G40.109S — Synthetic modern diagnosis echoing her documented convulsive seizures and transient right-sided paralysis; the hemiplegic migraine interpretation is recorded as R.
Acute viral gastroenteritis for two days, with vomiting of one levetiracetam dose, mild dehydration, and no seizure; resolved in four daysresolvedconfirmed A08.4S — Synthetic common illness chosen to teach antiseizure medicine adherence during vomiting; it echoes no documented illness.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
Self-managementSeizure diary, triggers (sleep loss, alcohol, missed doses), and seizure first aidEvery visitCompleted todayNo seizures in six and a half months; one vomited dose in August was managed by plan
SurveyPHQ-9, with a question about irritability on levetiracetamEvery visit while on levetiracetam and during cancer treatmentCompleted today4, minimal; counseling completed
SurveyGAD-7Every visit during the diagnostic and treatment phase; then as neededNot indicatedMild at the last visit and no anxiety reported now; to be repeated if symptoms return
SurveyCognitive screen after brain surgeryBaseline and after treatmentCompleted todayMoCA 29, up from 27 before surgery
LaboratoryKidney function on levetiracetamBaseline, then periodically, because the drug is cleared by the kidneysCompleted todayCreatinine 0.76 mg/dL; eGFR 95
ImagingSurveillance MRIYearly for five years after the three-month scanDueOne year after surgery
ExaminationEEG before any taperBefore deciding to stop an antiseizure medicineDueAt one year after surgery

Goal progress:

Guideline basis: EANO guideline on the diagnosis and management of meningiomas. Goldbrunner R, et al. Neuro Oncol 2021;23(11):1821-1834 (2021); Evidence-based guideline: Management of an unprovoked first seizure in adults. Krumholz A, et al. Neurology 2015;84(16):1705-1713 (2015); SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Walbert T, et al. Neuro Oncol 2021;23(11):1835-1844 (2021); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (depression screening and PHQ-9 follow-up) (2026)

Follow-up: Preventive visit next month; MRI and EEG at one year after surgery with a review of levetiracetam. Next scheduled visit 1849-10-20: adult preventive visit. [S]